Overview

Meeting: October 27-28 | In-Person

The DIA Canada Annual Meeting will provide an in-depth exploration of the current pharmaceutical, medical device, and diagnostic landscapes in Canada, emphasizing Canada’s pivotal role in global healthcare product development. Offering three specialized tracks on Regulatory, Clinical, and Safety and Pharmacovigilance, the meeting will cover topics spanning from Health Canada’s latest regulatory initiatives, international collaboration, and innovative clinical practices to approaches that harness AI in drug safety and increase representation from equity-denied groups.

Attendees will have the opportunity to engage with leaders and experts from academia, regulatory bodies, and the pharmaceutical and medical device industries by gaining insights into best practices, lessons learned, and strategies to address the challenges facing stakeholders in Canada.

While we develop our 2025 agenda, please take a moment to review the 2024 final agenda.

Participant Testimonials

Very meaningful topics, excellent speakers which allowed meaningful conversations. Size of the event also facilitates networking. - Véronique Lafrance, Senior Project Manager, Regulatory Affairs, Organon Canada

Amazing opportunity to meet PV and regulatory professionals from across Canada, learn about the challenges they face locally and in collaboration with their global affiliates. We enjoy being there every year! - Zenith PV – Exhibitor

The meeting presented a valuable learning opportunity, as we gained insights into best practices from different companies and heard the regulatory agency perspective. In addition to the professional development, DIA Canada 2024 provided an excellent networking platform to connect with peers and colleagues from across the industry and regulatory sphere. I really encourage others to join DIA's events and meetings in the future. - Vanessa Zapata, Associate Director, Regional Pharmacovigilance Officer, Merck Canada Inc.

Featured

Want to learn more about Canada Annual Meeting ? You've come to the right site!

Who should attend?

Meeting Designed For:

Join professionals interested in a comprehensive overview of the current biopharma pharmaceutical, medical device, and/or diagnostics landscape in Canada:
- Pharmacovigilance and Drug Safety
- Risk Management
- Clinical Research, Management, and Operations
- Regulatory Affairs and Operations
- Medical Affairs and Scientific Communication
- Quality Assurance
- Life Sciences R&D
- Project Management
- Real-World Data and Real-World Evidence
- Data Management

Program Committee

Melanie Cote, MS Senior Manager, Global Regulatory Affairs
Otsuka Pharmaceutical Development & Commercialization Inc., Canada
Marie-France Goyer, MSc Director, Clinical Operations
Abcellera, Canada
Nadiya Jirova, MSc Manager, Bureau of Biologics, Radiopharmaceuticals and Self-Care Products
Health Canada, Canada
Hocine Abid, MD, MBA National Manager, Regulatory Operations and Enforcement Branch
Health Canada, Canada
Stephanie Anderson, MS Associate Director, Regulatory Affairs
Intrinsik Corp., Canada
Rebecca Barnes, MS Executive Director
Network of Networks (N2), Canada
Katalin Bertenyi, MSc Manager, Centre for Blood, Blood Products and Biotherapeutics
Health Canada, Canada
Louise Blythe, MSc VP & Head, Regulatory Affairs
Bayer Inc. Canada, Canada
Anna Bussel Director Pharmacovigilance and Medical Information
Veristat, Canada
My Dang, MBA Director/Consultant, Regulatory Affairs
Cencora, Canada
Fernando Frankel linical Research Medical Advisor Oncology Solid Tumors/Radioligand Therapy Globa
Novartis, Canada
Tharany Ganesh, MSc Head, Regulatory Affairs
AstraZeneca Canada Inc., Canada
Daniel Greco, PharmD, RPh Associate Director of Patient Safety
Bristol-Myers Squibb Company, Canada
Yatika Kohli, PhD, MBA Chief Compliance and Strategy Officer
NoNO Inc, Canada
Mei Lam, BSN, RN Canada PV Manager/Safety Regional Country Contact
Haleon, Canada
Nadia Latif, MS Senior Manager, Pharmacovigilance
Ipsen Biopharmaceuticals Canada Inc., Canada
Randy Levitt, PhD Director, Pharmacovigilance and Medical Affairs
Paladin Pharma Inc., Canada
Kim McDonald-Taylor, MS, MSc Clinical Research Consultant
Clinical Research Association of Canada, Canada
Amber McLeod, PhD Immunology, Virology, and Specialty Head, Regulatory Affairs
Abbvie Corporation, Canada
Ricardo Pasquel Cook, MD Safety Team Lead
Pfizer Inc., Canada
Sabrina Ramkellawan Chief Operating Officer
AxialBridge, Canada
Marcia Sam Senior Manager, Regulatory Affairs
Regeneron Canada Company, Canada
Yulia Vasianovich, PhD, RAC Scientific Evaluator, Marketed Health Products Directorate
Health Canada, Canada